This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • Osimertinib for Patients With Non-Small-Cell Lung ...
Journal

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Read time: 1 mins
Published:9th Feb 2020
Author: Cho JH, Lim SH, An HJ, Kim KH, Park KU, Kang EJ et al.
Availability: Free full text
Ref.:J Clin Oncol. 2020 Feb 10;38(5):488-495.
DOI:10.1200/JCO.19.00931
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest